These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2609765)

  • 1. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
    Frolov VM; Peresadin NA; Gaĭdash IS; Baskakov IN; Tishchenko NA
    Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
    Sov Med; 1990; (6):111-3. PubMed ID: 2144365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
    Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin].
    Sarkisian SV
    Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of vilozen on the immune status of erysipelas patients and the prospects for its use for the immune rehabilitation of convalescents].
    Frolov VM; Peresadin NA; Pinskiĭ LL; Korobka IuN
    Lik Sprava; 1992; (11-12):102-4. PubMed ID: 1292201
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T-activin in the treatment of patients with recurrent aphthous stomatitis].
    Terekhova NV; Khazanova VV; Zemskaia EA; Bykova IA; Filonenko OF; Kosorukova NIa; Rabinovich IM
    Stomatologiia (Mosk); 1991; (2):35-7. PubMed ID: 1853375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of tactivin side effects in patient with eczema].
    Zaerko VV
    Klin Med (Mosk); 1991 May; 69(5):97-8. PubMed ID: 1857089
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
    Ianiushina VV
    Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrastructure of the blood lymphoid cells and the dynamics of cellular immunity indices in chronic lympholeukemia patients during immunocorrection with T-activin].
    Chuvirov GN; Markova TP
    Ter Arkh; 1986; 58(9):67-70. PubMed ID: 3787495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic and prognostic significance of the level of circulating immune complexes in patients with recurrent erysipelas].
    Frolov VM; Boĭchenko PK; Peresadin NA
    Vrach Delo; 1990 Jun; (6):116-8. PubMed ID: 2399704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunocorrecting therapy in focal scleroderma].
    Suchkova TN; Prozorovskaia NN; Suchkov SV; Del'vig AA
    Vestn Dermatol Venerol; 1987; (9):8-14. PubMed ID: 3424992
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and immunologic study on the efficacy of the leucotrophine treatment of patients with recurrent bronchopulmonary infections].
    Basacopol A; Popescu C; Esrig E; Nicolaescu O; Moldoveanu I; Bălună R; Belaşcu I; Eremia D; Ghyka P
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(1):63-8. PubMed ID: 2847302
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
    Mel'nik VP
    Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of taktivin in patients with viral myocarditis and dilated cardiomyopathy].
    Kipshidze NN; Dzhaparidze MM; Dzidziguri LM; Rachvelishvili NB; Dateshidze MN; Demetrashvili MF
    Ter Arkh; 1990; 62(9):116-8. PubMed ID: 2177920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indices of cellular and humoral immunity in patients with disseminated sclerosis being treated with immunomodulators].
    Zapadniuk BV; Kravets AS; Iarosh AA; Shurinok LA
    Vrach Delo; 1988 Aug; (8):84-6. PubMed ID: 3206892
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of circulating immune complexes in patients with erysipelas].
    Frolov VM; Bala MA; Frolov AF; Rychnev VE
    Vrach Delo; 1985 Jun; (6):102-5. PubMed ID: 3161244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.